propranolol has been researched along with lucifer yellow in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
| Aroniadou-Anderjaska, V; Braga, MF; Hough, CJ; Li, H; Manion, ST | 1 |
| Chow, AH; Zheng, Y; Zuo, Z | 1 |
| Altamura, M; Catalioto, RM; Festa, C; Giuliani, S; Maggi, CA; Triolo, A | 1 |
| Jin, H; Yang, S; Zhao, Z | 1 |
5 other study(ies) available for propranolol and lucifer yellow
| Article | Year |
|---|---|
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
Stress impairs alpha(1A) adrenoceptor-mediated noradrenergic facilitation of GABAergic transmission in the basolateral amygdala.
Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Aging; Amygdala; Anesthetics, Local; Animals; Animals, Newborn; Bicuculline; Body Weight; Dose-Response Relationship, Drug; Drug Interactions; Estrenes; Excitatory Amino Acid Antagonists; GABA Antagonists; gamma-Aminobutyric Acid; Imidazoles; In Vitro Techniques; Isoquinolines; Male; Membrane Potentials; Morpholines; Neural Inhibition; Neurons; Norepinephrine; Patch-Clamp Techniques; Phosphodiesterase Inhibitors; Propranolol; Pyrrolidinones; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Restraint, Physical; Stress, Physiological; Tetrahydronaphthalenes; Tetrodotoxin; Time Factors | 2004 |
Lack of effect of beta-cyclodextrin and its water-soluble derivatives on in vitro drug transport across rat intestinal epithelium.
Topics: Adrenergic beta-Antagonists; Animals; beta-Cyclodextrins; Diffusion Chambers, Culture; Drug Carriers; Fluorescent Dyes; Ileum; Intestinal Absorption; Intestinal Mucosa; Isoquinolines; Male; Osmolar Concentration; Permeability; Propranolol; Rats; Rats, Sprague-Dawley; Solubility; Water | 2006 |
Differential effect of ethanol and hydrogen peroxide on barrier function and prostaglandin E2 release in differentiated Caco-2 cells: selective prevention by growth factors.
Topics: Caco-2 Cells; Cell Differentiation; Cell Survival; Cyclooxygenase Inhibitors; Dinoprostone; Dose-Response Relationship, Drug; Electric Impedance; Epithelial Cells; Ethanol; Fibroblast Growth Factor 7; Fibroblast Growth Factors; Fluorescent Dyes; Hepatocyte Growth Factor; Humans; Hydrogen Peroxide; Insulin; Intercellular Signaling Peptides and Proteins; Irritants; Isoquinolines; L-Lactate Dehydrogenase; Permeability; Phenylalanine; Propranolol; Protein Kinase Inhibitors | 2009 |
An ECV304 monoculture model for permeability assessment of blood-brain barrier.
Topics: Blood-Brain Barrier; Capillary Permeability; Cell Culture Techniques; Cell Line; Central Nervous System Agents; Claudin-5; Digoxin; Fluorescent Antibody Technique; Fluorescent Dyes; Humans; Isoquinolines; Models, Neurological; Occludin; Propranolol; Quinidine; Zonula Occludens-1 Protein | 2018 |